Modupe Agunbiade, DPM
Foot & Ankle Surgery · East Orange, NJNPI 1528443033
Payments from drug & device makers
Across 119 payments — averaging $49.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1K
- Prodigy Surgical Distribution, Inc.$868
- Cardiovascular Systems Inc.$692
- Paratek Pharmaceuticals, Inc.$421
- Kerecis Limited$378
- Stryker$272
- plus $2K from 26 others
What the payments were for
- Travel & lodging$5199%
- Food & beverage$4,01668%
- Education$1,37523%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 4 | $1,162 |
| Prodigy Surgical Distribution, Inc. | 4 | $868 |
| Cardiovascular Systems Inc. | 6 | $692 |
| Paratek Pharmaceuticals, Inc. | 22 | $421 |
| Kerecis Limited | 3 | $378 |
| Stryker | 6 | $272 |
| Smith+Nephew | 10 | $254 |
| Inari Medical, Inc. | 2 | $210 |
| Paragon 28, Inc. | 2 | $170 |
| Nabriva Therapeutics, PLC | 11 | $150 |
| Next Science LLC | 3 | $147 |
| Integra Lifesciences Corporation | 2 | $136 |
| Sandoz | 7 | $135 |
| Advanced Oxygen Therapy Inc. | 2 | $134 |
| Cagent Vascular Inc | 1 | $125 |
| Treace Medical Concepts, Inc. | 5 | $102 |
| Organogenesis Inc. | 3 | $75 |
| Alfasigma USA, Inc. | 4 | $56 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $56 |
| KCI USA, Inc. | 2 | $43 |
| Convatec Inc. | 2 | $42 |
| Resmed Corp | 1 | $42 |
| Sebela Pharmaceuticals Inc. | 3 | $41 |
| Polynovo North America LLC | 1 | $38 |
| Solventum Corporation | 1 | $27 |
| Orthofix Medical, Inc. | 1 | $22 |
| Urgo Medical North America, LLC | 1 | $22 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $21 |
| Abbott | 1 | $20 |
| Averitas Pharma Inc. | 1 | $18 |
| Acera Surgical, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$954
- Diamondback Peripheral$387
- INTEGRA$330
- Kerecis Omega3 SurgiClose$239
- PHANTOM Hindfoot$150
- SurgX$128
- Xperience$128
- BlastX$128
- Peripheral Orbital Atherectomy System$128
- Serrantor$125
- AUGMENT INJECTABLE$120
- COLLAGENASE SANTYL$115
- INTEGRA DERMAL REGENERATION TEMPLATE$110
- PRIMATRIX$110
- NUZYRA$108
- FLOWTRIEVER CATHETER, S$108
- CT THROMBECTOMY SYSTEM KIT$108
- Topical oxygen chamber for extremities$107
- LIMFLOW SYSTEM$103
How this compares
$5,909 in reported general payments places this provider in the 75th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 15 | $9,167 |
| CiclopiroxCiclopirox Olamine | 124 | $3,217 |
| Ciclopirox | 50 | $1,951 |
| Diclofenac Sodium | 11 | $1,272 |
| Ketoconazole | 54 | $1,027 |
| Ammonium Lactate | 16 | $363 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $254 | $9,16715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 542 foot & ankle surgery providers in New Jersey.
Other foot & ankle surgery in East Orange
- Wayne BerberianNewark$2M
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$847K
- Shane HollawellManasquan$753K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Sheldon LinNewark$253K
- Mark SolomonCedar Knolls$232K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.